NYXOAH SA - ORDINARY SHARES

Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program

22 дек 2022 16:12:14 Источник Nasdaq GlobeNewswire

Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference

17 ноя 2022 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Reports Third Quarter 2022 Financial and Operating Results

08 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces Change to Board of Directors

24 окт 2022 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah to Participate in the Jefferies London Healthcare Conference

20 окт 2022 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah to Release Third Quarter Financial Results on November 8, 2022

18 окт 2022 16:30:00 Источник Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

30 сен 2022 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference

18 авг 2022 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results

08 авг 2022 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test

02 авг 2022 02:00:00 Источник Nasdaq GlobeNewswire

Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference

27 июл 2022 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022

19 июл 2022 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces CE Mark Approval for Genio® 2.1

18 июл 2022 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients

11 июл 2022 02:00:00 Источник Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

30 июн 2022 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Joins the Euronext Tech Leaders Initiative, Included in the Euronext Tech Leaders Index

07 июн 2022 16:30:00 Источник Nasdaq GlobeNewswire

FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study

01 июн 2022 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Reports First Quarter 2022 Financial and Operating Results

10 май 2022 02:55:00 Источник Nasdaq GlobeNewswire

Nyxoah Reports First Quarter 2022 Financial and Operating Results

09 май 2022 16:30:00 Источник Nasdaq GlobeNewswire

Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 8, 2022

06 май 2022 01:00:00 Источник Nasdaq GlobeNewswire